News | Magnetic Resonance Imaging (MRI)

Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a study of how single-center stress cardiovascular magnetic resonance (CMR) research studies have shown excellent values in management of patients with suspected ischemia. Kwong, who is also a member of the Society for Cardiovascular Magnetic Resonance (SCMR) presented his findings at the 2018 European Society of Cardiology (ESC) Congress, Aug. 25-29 in Munich, Germany.

Home September 17, 2018
Home
News | Heart Valve Technology

September 17, 2018 — 4C Medical Technologies Inc. announced that its AltaValve transcatheter mitral valve replacement ...

Home September 17, 2018
Home
News | Computed Tomography (CT)

September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare ...

Home September 17, 2018
Home
Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics. #TCT #TCT18 #TCT2018
Feature | TCT | Dave Fornell, Editor

The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventional ...

Home September 14, 2018
Home
Sponsored Content | Feature | Atrial Fibrillation

Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time ...

Home September 13, 2018
Home
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell
Feature | Cath Lab | Artur Kim, Kamran Zamanian

Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and ...

Home September 13, 2018
Home
News | Contrast Media

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore ...

Home September 12, 2018
Home
Videos | Stents

This is an animation showing how the dedicated bifurcation stent developed by Advanced Bifurcation Systems (ABS) is ...

Home September 11, 2018
Home
Videos | Cardiac Imaging

Leslee Shaw, Ph.D., professor of cardiology and radiology, Weill Cornell Medical Center, New York, and past-president of ...

Home September 10, 2018
Home
News | Heart Failure

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm and coronary artery disease. These conclusions came from late-breaking results from the COMMANDER HF trial presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2018, Aug. 25-28 in Munich, Germany, and with simultaneous publication in the New England Journal of Medicine.1

Home September 07, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLC’s (TSI) sequential dual-treatment regimen of low-dose tissue plasminogen activator (tPA) and HisproUK (TSI’s mutant prourokinase [proUK]) in ischemic stroke patients. The study follows a recently completed Phase 1 study that confirmed the safety and tolerability of TSI’s regimen in healthy volunteers (n=26).

Home September 07, 2018
Home
News | Heart Failure

Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart condition called transthyretin amyloid cardiomyopathy, according to late-breaking research presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2018 and published in the New England Journal of Medicine.

Home September 06, 2018
Home
News | Cardiovascular Surgery

While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary artery bypass graft (CABG) surgery compared to vein grafts, it is not known if there are additional benefits with the use of a second artery. This was explored in the ten-year outcomes of the Arterial Revascularisation Trial (ART) presented in a Hot Line Session at the European Society of Cardiology (ESC) Congress 2018, Aug. 25-28 in Munich, Germany.

Home September 06, 2018
Home
News | Heart Valve Technology

W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately held medical technology company focused on advancing chordal repair for degenerative mitral regurgitation (DMR) via a transcatheter procedure.

Home September 06, 2018
Home
News | Computed Tomography (CT)

The Center for Diagnostic Imaging (CDI) in Miami recently released a list of important preparations patients should make before undergoing a computed tomography (CT) scan.

Home September 05, 2018
Home
Subscribe Now